‘Approval of Covaxin a milestone for Indian vaccinology’

The Drugs Controller General of India on Sunday gave the permission to Bharat Biotech's Covaxin for use in an emergency situation.

Bengaluru: Karnataka Health Minister Dr K Sudhakar lauded the approval of Bharat Biotech’s COVID vaccine ‘Covaxin’ today and called it a significant milestone in India’s indigenous novel vaccinology.

“India being one of the largest exporters of vaccines, the world is looking up to us in the common fight against this global pandemic. Bharat Biotech is a globally reputed company which has the credibility and experience of developing 16 vaccines including for influenza H1N1, Rotavirus, Japanese Encephalitis, Rabies, Chikungunya, Zika and the world’s first tetanus-toxoid conjugated vaccine for Typhoid,” he said in a tweet.

---

Bharat Biotech is a globally reputed company which has the credibility and experience of developing 16 vacvines including for influenza H1N1, Rotavirus, Japanese Encephalitis, Rabies, Chikungunya, Zika and the world’s first tetanus-toxoid conjugated vaccine for Typhoid. (2/4)

— Dr Sudhakar K (@mla_sudhakar) January 5, 2021

Dr Sudhakar also praised Bharat Biotech’s founder and Chairman Dr Krishna Ella saying that he is a passionate professional with the credibility of delivering over 4 billion vaccine doses to underprivileged people in more than 150 developing countries through UNICEF and other channels.

He also said that the phase III clinical trials of Covaxin involve 24,000 volunteers and the data of the trials will be made available soon. The minister also appealed to the people to not indulge in criticism of the vaccine as it discredits the hard work of scientists.

Covaxin’s phase-3 clinical trial involves 24,000 volunteers & it’s data will be available soon. I humbly appeal to everyone, not as a Health Minister but as a fellow medical professional, to refrain from unwarranted criticism which discredits the hard work of our scientists.(4/4)

— Dr Sudhakar K (@mla_sudhakar) January 5, 2021

The Drugs Controller General of India on Sunday gave the permission to Bharat Biotech’s Covaxin for use in an emergency situation.